Find a Tender
complete
Official procurement procedure
Primary Care Sheffield Limited & NHS South Yorkshire ICB Tele-dermatology USC Emergency Provision 2024/25
Dermatology services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS South Yorkshire Integrated Care Board: "Primary Care Sheffield Limited & NHS South Yorkshire ICB Tele-dermatology USC Emergency Provision 2024/25". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS South Yorkshire Integrated Care Board | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS South Yorkshire Integrated Care Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS South Yorkshire Integrated Care Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 651 active published awards; 645 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS South Yorkshire Integrated Care Board | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published3 Jan 2025, 15:31 GMT | Last source update3 Jan 2025, 15:31 GMT | Recurring procurementNot published |
ClassificationDermatology services | ||
Delivery area | ||
OCIDocds-h6vhtk-04cd66 | ||
What is being bought
Tele-dermatology for Sheffield: An imaging service, for those GPs who are unable to take images to attach to urgent suspected skin cancer referrals, a service whereby a third party will capture the image on behalf of the GP and attach to the referral.
What changed
From the official release history
- Status changed to complete
3 Jan 2025, 15:31 GMT - Official notice release published
3 Jan 2025, 15:31 GMT - Buyer information updated
3 Jan 2025, 15:31 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe relevant authority, NHS South Yorkshire Integrated Care Board (SYICB) believe this award of a dermatology imaging contract, to Primary Care Sheffield Limited, is urgent.<br/><br/>Following the regulations below from the Provider Selection Regime (PSR) the contract has been awarded under the Health Care Services Regulations 2023.<br/><br/>Regulation 14(2)(a) of the Provider Selection Regime: The authority considers that the award must be made urgently<br/><br/>The authority considers that the award must be made urgently.<br/>Sheffield Teaching Hospitals have recently been under increasing national scrutiny as the worst performer in the country for the Faster Diagnosis Standard in skin cancer which is being correlated with them being the only provider without a comprehensive tele dermatology service. Tier 1 conversations have requested urgent action to recover this position. <br/><br/>Some short term waiting list initiatives have been implemented to improve the position but this remains fragile due to ongoing capacity constraints and there still being insufficient capacity to match demand. There is well-recognised seasonal variation with skin cancer referrals leading to increased referrals over summer when the service is often most stretched for capacity. There are also concerns regarding waiting times for non-skin cancer conditions which have a serious quality of life implication. Awarding the teledermatology contract will allow consultant led triage of the urgent suspected cancers ensuring that the referrals into STHFT are limited to those definitely requiring secondary care input and releasing capacity to manage the whole PTL. <br/><br/>Regulation 14(2)(b): The reason for the urgency was not foreseeable by and not attributable to the relevant authority<br/>Less than 6 months ago STH were performing above the FDS target for skin and whilst performance declined during the winter it was not expected that this would drop as significantly below target as it did and continuing on a downward trajectory. A local incentivisation scheme was implemented to ensure dermatology image capture in primary care but this has not yielded the productivity gains that have been demonstrated by utilisation of a tele-dermatology provider.<br/>The reason for the poor performance is not attributable to SYICB but a result of combined demand and capacity pressures at STH. <br/><br/>Regulation 14(2)(c): Delaying the award of the contract to satisfy the requirements of the other relevant PSR regulations would likely pose a risk to patient or public safety<br/>There is an immediate risk to patient safety due to delays in cancer diagnosis. The FDS is described by NHS England as being essential to ensure patients who are diagnosed with cancer can begin their treatment as soon as possible, and put those who are not diagnosed with cancer at ease sooner (see https://www.england.nhs.uk/cancer/faster-diagnosis/). The aim of this emergency tele-dermatology provision is to reduce the number of referrals on the USC skin pathway at STH (slowing demand) by ensuring only those genuine USCs are referred on the USC pathway and start their treatment as soon as possible.<br/><br/>The contract has been awarded for 6 months from 5th December 2024 with an option to extend on a rolling monthly basis for an additional 6 months (total contract term maximum of 12 months). <br/><br/>Rolling extension will be used where:<br/>a) provision identifies a reduction in demand on the USC skin pathway in Sheffield by improving the quality of images sent with referrals; <br/>b) this reduction in demand is contributing to the skin Faster Diagnosis Standard (FDS) recovery at Sheffield Teaching Hospitals NHS Foundation Trust (STH); and<br/>c) if a provision is deemed as required in Sheffield post the initial 6 months, to allow time for any discussions with primary care on the longer term approach to image capture and any resulting decisions to be undertaken in accordance with the relevant legislation and mobilised. <br/><br/>The lifetime value of the contract will be £110,861.50 (total over the maximum available 12 month term).This is new service with a new provider.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
3 Jan 2025, 15:31 GMT - Award active
Not published · Not published - Contract active
Signed 5 Dec 2024, 00:00 GMT · £110,862
Commercial outcome and competition
Awards Primary Care Sheffield Ltd Not published · Not published · active |
Contracts Contract £110,862 · signed 5 Dec 2024, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
NHS South Yorkshire Integrated Care Board
Contracting authority GB-FTS-113634Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThis award has been made following the regulations stated below from the Provider Selection Regime.<br/><br/>Regulation 14(2)(a): The authority considers that the award must be made urgently<br/>STH have recently been under increasing national scrutiny as the worst performer in the country for the Faster Diagnosis Standard in skin cancer which is being correlated with them being the only provider without a comprehensive tele dermatology service. Tier 1 conversations have requested urgent action to recover this position. <br/><br/>Some short term waiting list initiatives have been implemented to improve the position but this remains fragile due to ongoing capacity constraints and there still being insufficient capacity to match demand. There is well-recognised seasonal variation with skin cancer referrals leading to increased referrals over summer when the service is often most stretched for capacity. There are also concerns regarding waiting times for non-skin cancer conditions which have a serious quality of life implication. Awarding the teledermatology contract will allow consultant led triage of the urgent suspected cancers ensuring that the referrals into STHFT are limited to those definitely requiring secondary care input and releasing capacity to manage the whole PTL. <br/><br/>Regulation 14(2)(b): The reason for the urgency was not foreseeable by and not attributable to the relevant authority<br/>Less than 6 months ago STH were performing above the FDS target for skin and whilst performance declined during the winter it was not expected that this would drop as significantly below target as it did and continuing on a downward trajectory. A local incentivisation scheme was implemented to ensure dermatology image capture in primary care but this has not yielded the productivity gains that have been demonstrated by utilisation of a tele-dermatology provider.<br/>The reason for the poor performance is not attributable to SYICB but a result of combined demand and capacity pressures at STH. <br/><br/>Regulation 14(2)(c): Delaying the award of the contract to satisfy the requirements of the other relevant PSR regulations would likely pose a risk to patient or public safety<br/>There is an immediate risk to patient safety due to delays in cancer diagnosis. The FDS is described by NHS England as being essential to ensure patients who are diagnosed with cancer can begin their treatment as soon as possible, and put those who are not diagnosed with cancer at ease sooner (see https://www.england.nhs.uk/cancer/faster-diagnosis/). The aim of this emergency tele-dermatology provision is to reduce the number of referrals on the USC skin pathway at STH (slowing demand) by ensuring only those genuine USCs are referred on the USC pathway and start their treatment as soon as possible. |